Study 2: response to pulmonary rehabilitation in COPD patients who were or were not taking an ACE-I or ARB.
| ARB or ACE-I n=76 | No ARB or ACE-I n=179 | p value | |
|---|---|---|---|
| ΔFFM (kg) | −1.7 (2.7) | 1.8 (1.4) | 0.21 |
| ΔISWD (m) | 104 (21) | 63 (15) | 0.13 |
| ΔCRQ | 16.2 (3.8) | 17.7 (2.5) | 0.75 |
ACE-I, ACE inhibitors; ARB, AT II receptor antagonist; FFM, fat free mass; ISWD, incremental shuttle walk test distance; CRQ, chronic respiratory disease questionnaire.
All p>0.05. Data are presented as mean (SD).